ShotSpotter (SSTI) 10-Q 15 May 24 2024 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2024	May 08, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Trading Symbol	SSTI
Entity Registrant Name	SoundThinking, Inc.
Entity Central Index Key	0001351636
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity File Number	001-38107
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-0949915
Entity Address, Address Line One	39300 Civic Center Dr.
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Fremont
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94538
City Area Code	510
Local Phone Number	794-3100
Entity Current Reporting Status	Yes
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		12,793,456
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common stock, par value $0.005 per share
Security Exchange Name	NASDAQ
Document Quarterly Report	true
Document Transition Report	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 8,524	$ 5,703
Accounts receivable and contract assets, net	35,201	30,700
Prepaid expenses and other current assets	3,507	3,902
Total current assets	47,232	40,305
Property and equipment, net	21,429	21,028
Operating lease right-of-use assets	2,078	2,315
Goodwill	34,213	34,213
Intangible assets, net	35,995	36,938
Other assets	4,025	3,909
Total assets	144,972	138,708
Current liabilities
Accounts payable	2,260	3,031
Accrued expenses and other current liabilities	7,101	8,521
Line of credit	7,000	7,000
Deferred revenue, short-term	44,817	41,265
Total current liabilities	61,178	59,817
Deferred revenue, long-term	5,935	812
Deferred tax liability	1,267	1,226
Other liabilities	1,833	2,096
Total liabilities	70,213	63,951
Commitments and contingencies (Note 13)
Stockholders' equity
Common stock: $0.005 par value; 500,000,000 shares authorized; 12,793,168 and 12,761,448 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	64	64
Additional paid-in capital	173,066	170,139
Accumulated deficit	(98,027)	(95,118)
Accumulated other comprehensive loss	(344)	(328)
Total stockholders' equity	74,759	74,757
Total liabilities and stockholders' equity	$ 144,972	$ 138,708

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.005	$ 0.005
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	12,793,168	12,761,448
Common stock, shares outstanding	12,793,168	12,761,448

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 25,410	$ 20,620
Costs
Cost of revenues	10,271	9,243
Impairment of property and equipment	252	72
Total costs	10,523	9,315
Gross profit	14,887	11,305
Operating expenses
Sales and marketing	7,112	5,848
Research and development	3,560	2,653
General and administrative	6,830	4,616
Change in fair value of contingent consideration	0	(6)
Total operating expenses	17,502	13,111
Operating loss	(2,615)	(1,806)
Other income (expense), net
Interest income (expense), net	(122)	54
Other expense, net	(58)	(38)
Total other income (expense), net	(180)	16
Loss before income taxes	(2,795)	(1,790)
Provision for income taxes	114
Net loss	$ (2,909)	$ (1,790)
Net loss per share, basic	$ (0.23)	$ (0.15)
Net loss per share, diluted	$ (0.23)	$ (0.15)
Weighted-average shares used in computing net loss per share, basic	12,770,988	12,252,517
Weighted-average shares used in computing net loss per share, diluted	12,770,988	12,252,517

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (2,909)	$ (1,790)
Other comprehensive loss:
Change in foreign currency translation adjustment, net of taxes	(16)	(17)
Comprehensive loss	$ (2,925)	$ (1,807)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2022	$ 60,945	$ 62	$ 153,573	$ (92,400)	$ (290)
Beginning balance, Shares at Dec. 31, 2022		12,243,929
Exercise of stock options	127		127
Exercise of stock options, Shares		10,063
Repurchase of common stock	(1,256)		(1,256)
Repurchase of common stock, Shares		(35,369)
Issuance of common stock from RSUs vested, Shares		25,157
Stock-based compensation	2,220		2,220
Foreign currency translation loss	(17)				(17)
Net loss	(1,790)			(1,790)
Ending balance at Mar. 31, 2023	60,229	$ 62	154,664	(94,190)	(307)
Ending balance, Shares at Mar. 31, 2023		12,243,780
Beginning balance at Dec. 31, 2023	74,757	$ 64	170,139	(95,118)	(328)
Beginning balance, Shares at Dec. 31, 2023		12,761,448
Issuance of common stock from RSUs vested, Shares		31,720
Stock-based compensation	2,927		2,927
Foreign currency translation loss	(16)				(16)
Net loss	(2,909)			(2,909)
Ending balance at Mar. 31, 2024	$ 74,759	$ 64	$ 173,066	$ (98,027)	$ (344)
Ending balance, Shares at Mar. 31, 2024		12,793,168

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (2,909)	$ (1,790)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation of property and equipment	1,573	1,771
Amortization of intangible assets	965	661
Impairment of property and equipment	252	72
Stock-based compensation	2,927	2,220
Change in fair value of contingent consideration		(6)
Deferred taxes	41
Allowance for credit losses	126	25
Changes in operating assets and liabilities:
Accounts receivable and contract assets	(4,627)	4,211
Prepaid expenses and other assets	278	(486)
Accounts payable	(886)	219
Accrued expenses and other liabilities	(1,438)	(1,834)
Deferred revenue	8,675	(6,261)
Net cash provided by (used in) operating activities	4,977	(1,198)
Cash flows from investing activities:
Purchase of property and equipment	(2,134)	(1,537)
Investment in intangible and other assets	(6)	(23)
Net cash used in investing activities	(2,140)	(1,560)
Cash flows from financing activities:
Payment of contingent consideration liability		(1,500)
Proceeds from line of credit	3,000
Proceeds from exercise of stock options		127
Repurchases of common stock		(1,256)
Payment of line of credit	(3,000)
Net cash used in financing activities		(2,629)
Change in cash, cash equivalents and restricted cash	2,837	(5,387)
Effect of exchange rate on cash and cash equivalents	(16)	(17)
Cash, cash equivalents at beginning of year	5,703	10,479
Cash, cash equivalents at end of period	8,524	5,075
Supplemental cash flow disclosures:
Property and equipment purchases included in accounts payable	$ 584	$ 1,074

Organization and Description of

Organization and Description of Business	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Note 1. Organization and Description of Business SoundThinking, Inc. (the “Company”) brings the power of digital transformation to law enforcement and security personnel by providing precision-policing and security solutions, combining data-driven solutions and strategic advisory services for law enforcement and civic leadership. As of March 31, 2024, the Company had approximately 250 customers and to date have worked with approximately 2,100 agencies to help drive more efficient, effective, and equitable public safety outcomes. In April 2023, the Company introduced its SafetySmart™ platform that includes five data-driven tools consisting of (i) its flagship product, ShotSpotter® (formerly ShotSpotter Respond), the leading outdoor gunshot detection, location and alerting system trusted by 171 cities and 18 universities and corporations as of March 31, 2024, (ii) CrimeTracer™ (formerly COPLINK X), a leading law enforcement search engine that enables investigators to search through more than one billion criminal justice records across jurisdictions to generate tactical leads and quickly make intelligent connections to solve crimes, (iii) CaseBuilder™ (formerly ShotSpotter Investigate), a one-stop investigative management system for tracking, reporting, and collaborating on cases, (iv) ResourceRouter™ (formerly ShotSpotter Connect) that directs the deployment of patrol and community anti-violence resources in an objective way to help maximize the impact of limited resources and improve community safety, and (v) SafePointe™, an AI-based weapons detection system that the Company added when it acquired SafePointe, LLC (“SafePointe”) in August 2023. The Company offers its solutions on a software-as-a-service subscription model to its customers. ShotSpotter for Highways, ShotSpotter for Campus and ShotSpotter for Corporate, are typically smaller-scale deployments of ShotSpotter vertically marketed to universities, corporate campuses, highways, and key infrastructure centers to mitigate risk and enhance security by notifying authorities of outdoor gunfire incidents, saving critical minutes for first responders to arrive. In 2019, the Company created a technology innovation unit, SoundThinking Labs, to expand its efforts supporting innovative uses of its technology to help protect wildlife and the environment. Additionally, the Company provides maintenance and support services and professional software development services to two customers, through sales channel intermediaries. The Company’s principal executive offices are located in Fremont, California. The Company has six wholly-owned subsidiaries.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements include the results of the Company and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated upon consolidation. The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the consolidated financial statements filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (“Annual Report”) filed with the SEC on April 1, 2024. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss, stockholders’ equity and cash flows for the interim periods, but are not necessarily indicative of the results of operations or cash flows to be anticipated for the full year 2024 or any future period. The Company has evaluated subsequent events occurring after the date of the condensed consolidated financial statements for events requiring recording or disclosure in the condensed consolidated financial statements. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its significant estimates, including the valuation of accounts receivable, the lives and realization of tangible and intangible assets, contingent consideration liabilities, stock-based compensation expense, customer life, accounting for revenue recognition, contingent liabilities related to legal matters, and income taxes including deferred taxes and any related valuation allowance. In particular, the Company's contingent consideration liabilities are subject to significant estimates surrounding forecasts of certain revenues and other factors. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could be material to the Company’s financial position and results of operations. The Company records net deferred tax assets to the extent the Company believes these assets will more likely than not be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. In the event the Company determines that it would be able to realize its deferred assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. Concentrations of Risk Credit Risk – Financial instruments that potentially subject the Company to concentration of credit risk consisted primarily of cash and cash equivalents and accounts receivable from trade customers. The Company maintains its deposits of cash and cash equivalents at three domestic and four international financial institutions. The Company is exposed to credit risk in the event of default by a financial institution to the extent that cash and cash equivalents are in excess of the amount insured by the Federal Deposit Insurance Corporation ("FDIC") and other local country government agencies. The Company generally places its cash and cash equivalents with high-credit quality financial institutions. To date, the Company has not experienced any losses on its cash and cash equivalents. As of March 31, 2024, the Company had approximately $ 7.6 million, $ 0.3 million and $ 27,000 , deposited with the Company's three domestic financial institutions, for which only $ 250,000 per bank is insured under FDIC limits. Concentration of Accounts Receivable and Contract Assets – At March 31, 2024 , two customers accounted for 25 % and 21 % of the Company’s total accounts receivable and contract assets, net. At December 31, 2023, two customers accounted for 24 % and 10 %, respectively, of the Company’s total accounts receivable and contract assets, net. Concentration of Revenues – For the three months ended March 31, 2024 , two customers accounted for 26 % and 10 % of the Company’s total revenues. For the three months ended March 31, 2023, two customers accounted for 27 % and 10 % of the Company’s total revenues. Concentration of Suppliers – The Company relies on a limited number of suppliers and contract manufacturers. In particular, a single supplier is currently the sole manufacturer of the Company’s proprietary sensors. During the three months ended March 31, 2024, there were no changes to the Company’s significant accounting policies described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, except as follows: Recent Accounting Pronouncements Not Yet Effective Improvements to Income Tax Disclosures In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 enhances the transparency of income tax disclosures, primarily by requiring public business entities to disclose on an annual basis, specific categories in the rate reconciliation tabular presentation, as well as by providing additional information for reconciling items that meet a quantitative threshold. The ASU also requires disaggregated disclosures of federal, state and foreign income taxes paid. The new guidance is effective for fiscal years beginning after December 15, 2024. The Company does not expect implementation of the new guidance to have a material impact on its condensed consolidated financial statements. Improvements to Reportable Segment Disclosures In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which enhances prior reportable segment disclosure requirements in part by requiring entities to disclose significant expenses related to their reportable segments. The guidance also requires disclosure of the Chief Operating Decision Maker's (“CODM”) position for each segment and detail of how the CODM uses financial reporting to assess their segment’s performance. The new guidance is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, on a retrospective basis, with early adoption permitted. The Company does not expect implementation of the new guidance to have a material impact on its consolidated financial statements.

Revenue Related Disclosures

Revenue Related Disclosures	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Related Disclosures	Note 3. Revenue Related Disclosures The changes in deferred revenue were as follows (in thousands): March 31, 2024 2023 Beginning balance $ 42,077 $ 43,721 New billings 33,242 14,149 Revenue recognized during the year from beginning balance ( 14,347 ) ( 14,987 ) Revenue recognized during the year from new billings ( 10,220 ) ( 5,429 ) Foreign currency impact — 5 Ending balance $ 50,752 $ 37,459 The following table presents remaining performance obligations for contractually committed revenues as of March 31, 2024 (in thousands): Remainder of 2024 $ 59,125 2025 33,158 2026 16,135 Thereafter 5,340 Total $ 113,758 The timing of certain revenue recognition included in the table above is based on estimates of go-live dates for contracts not yet live. Contractually committed revenue includes deferred revenue as of March 31, 2024 and amounts under contract that will be invoiced after March 31, 2024. During the three months ended March 31, 2024, the Company recognized revenues of $ 24.8 million from customers in the United States, and $ 0.6 million from customers in the Bahamas, South Africa and Uruguay. During the three months ended March 31, 2023, the Company recognized revenues of $ 20.2 million from customers in the United States, and $ 0.4 million from customers in the Bahamas and South Africa. During the three months ended March 31, 2024 , the Company recognized revenues of $ 25.3 million from monthly subscription, maintenance and support services, and $ 0.1 million from professional software development services. During the three months ended March 31, 2023, the Company recognized revenues of $ 19.5 million from monthly subscription, maintenance and support services, and $ 1.1 million from professional software development services.

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2024
Business Combinations [Abstract]
Acquisitions	Note 4. Acquisitions SafePointe, LLC During the third quarter of 2023, the Company completed the acquisition of 100 % of the membership interests in SafePointe for purchase consideration of $ 11.4 million in cash, subject to working capital adjustments, of which $ 1.1 million is indemnification escrow cash, and $ 11.2 million in the form of 549,579 shares of the Company's common stock based on the closing price on the date of acquisition, of which $ 1.1 million is indemnification escrow stock. The purchase consideration also included a contingent earnout payable based on SafePointe’s revenues generated during 2023 through 2025. The Company borrowed $ 7.0 million under the Umpqua Credit Agreement (See Note 12, Financing Arrangements ) to partially fund the purchase consideration. The acquisition date fair value of the contingent earnout was $ 3.0 m illion, resulting in a total purchase consideration of $ 25.6 million. Up to $ 11.5 million in earnout would be payable based on SafePointe’s revenues generated during the remainder of 2023 and during the years ended December 31, 2024 and 2025. The SafePointe acquisition was accounted for as a business acquisition in accordance with ASC 805, Business Combinations . The acquisition allows the Company to enter the AI-based weapons detection market. The following table summarizes the assignment of fair value to the identified assets and liabilities recorded as of the acquisition date (in thousands): Cash and cash equivalents $ 394 Accounts receivable and contract assets 370 Property and equipment, net 717 Customer relationships 2,500 Software technology 9,200 Tradename 1,100 Goodwill 11,242 Other assets 101 Accrued expenses and other current liabilities ( 52 ) Deferred revenue ( 581 ) Net assets acquired 24,991 Escrow claim 581 Total estimated consideration $ 25,572 The goodwill recognized was primarily attributed to increased synergies that are expected to be achieved from the integration of SafePointe and primarily represents the value of cash flows from future customers and the employee workforce. The Company expects to deduct the amortization of goodwill and intangible assets for tax purposes. A portion of the amortization deduction will commence upon settlement of contingent consideration liabilities. The Company valued the intangible assets using income-based approaches. Significant assumptions included forecasts of revenues, cost of revenues, research and development expense, sales and marketing expense, general and administrative expense, technology lives, royalty rates, working capital rates, customer attrition rates and other estimates. The Company discounted the cash flows at 20.9 %, reflecting the risk profile of the assets. The Company will amortize the acquired customer relationships for 12 years, the acquired software technology for 11 years and the acquired tradename for nine years . There were no acquisition-related expenses during the three months ended March 31, 2024 and 2023, respectively. The unaudited pro forma combined revenue and net loss presented below have been prepared as if the Company had acquired SafePointe on January 1, 2023 and is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisition had taken place on January 1, 2023. The unaudited pro forma financial information has been derived from the consolidated statements of operations of the Company and SafePointe for the below period. The historical financial information has been adjusted in the unaudited combined pro forma information based upon currently available information and certain estimates and assumptions. The actual effect of the transactions ultimately may differ from the pro forma adjustments included herein. However, management believes that the assumptions used to prepare the pro forma adjustments provide a reasonable basis for presenting the significant effects of the transactions as currently contemplated and that the pro forma adjustments are factually supportable, give appropriate effect to the expected impact of events that are directly attributable to the transactions, and reflect those items expected to have a continuing impact on the Company. The unaudited pro forma combined revenue and net loss for the three months ended March 31, 2023 would have been $ 21.0 million and $ 2.4 million, respectively.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 5. Fair Value Measurements In November 2020, the Company estimated the fair value of the contingent consideration liability associated with its acquisition of LEEDS, LLC (“LEEDS”). This fair value measurement was classified as Level III within the fair value hierarchy as prescribed by Accounting Standards Codification 820-10-35-37 ("ASC 820, Fair Value Measuremen t"). In May 2023, the Company renamed LEEDS to Technologic Solutions, LLC (“Technologic”). During the first quarter of 2023, the Company paid the $ 1.5 million Technologic contingent consideration balance, in full settlement of its obligations under the purchase agreement. In January 2022, the Company estimated the fair value of the contingent consideration liability associated with its acquisition of Forensic Logic to be $ 12.4 million as of the acquisition date, using a Monte Carlo simulation approach with asset and revenue volatility of 60.0 % and 28.0 %, respectively. This fair value measurement is classified as Level III within the fair value hierarchy as prescribed by ASC 820, Fair Value Measurement . During the three months ended March 31, 2023, the fair value of the contingent consideration was decreased by $ 0.01 million, based upon adjustments to recorded liabilities as a result of revised 2023 forecasted revenues as of March 31, 2023. As a result of actual revenue recognized in the year ended December 31, 2023, the Company did not pay any amounts under the contingent consideration and no further contingent payments remain. In August 2023, the Company estimated the fair value of the contingent consideration liability associated with its acquisition of SafePointe to be $ 3.0 million as of the acquisition date, using a Monte Carlo simulation approach with asset and revenue volatility of 76.1 % and 25.8 %, respectively. This fair value measurement is classified as Level III within the fair value hierarchy as prescribed by ASC 820, Fair Value Measurement . The changes in the fair value of contingent consideration liabilities for the three months ended March 31, 2024 and 2023 are as follows (in thousands): Three Months Ended March 31, 2024 2023 Beginning balance $ 554 $ 4,747 Payment of contingent consideration liability — ( 1,500 ) Change in fair value of contingent consideration — ( 6 ) Ending balance $ 554 $ 3,241 There were no transfers into or out of Level III during the three months ended March 31, 2024 and 2023. As of March 31, 2024, the SafePointe contingent consideration of approximately $ 0.6 million is included in other liabilities in th e condensed consolidated balance sheet.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 6. Goodwill The change in goodwill is as follows (in thousands): March 31, December 31, 2024 2023 Beginning balance $ 34,213 $ 22,971 Acquisition of SafePointe (Note 4 - Acquisitions) — 11,242 Ending balance $ 34,213 $ 34,213

Intangible Assets, Net

Intangible Assets, Net	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	Note 7. Intangible Assets, Net Intangible assets consist of the following (in thousands): March 31, 2024 Weighted Average Amortization Period (in years) Gross Accumulated Amortization Net Customer relationships 14 $ 25,470 $ ( 4,927 ) $ 20,543 Acquired software technology 9 16,340 ( 2,627 ) 13,713 Patents and intellectual property 4 1,988 ( 1,273 ) 715 Tradename 6 2,100 ( 1,076 ) 1,024 Total intangible assets, net $ 45,898 $ ( 9,903 ) $ 35,995 December 31, 2023 Weighted Average Amortization Period (in years) Gross Accumulated Amortization Net Customer relationships 14 $ 25,470 $ ( 4,467 ) $ 21,003 Acquired software technology 9 16,340 ( 2,199 ) 14,141 Patents 4 1,966 ( 1,227 ) 739 Tradename 6 2,100 ( 1,045 ) 1,055 Total intangible assets, net $ 45,876 $ ( 8,938 ) $ 36,938 Intangible amortization expense was approximately $ 1.0 million and $ 0.7 million for the three months ended March 31, 2024 and March 31, 2023, respectively. The following table presents future intangible asset amortization as of March 31, 2024 (in thousands): Remainder of 2024 $ 2,857 2025 3,818 2026 3,801 2027 3,801 2028 3,736 Thereafter 17,982 Total $ 35,995

Details of Certain Condensed Co

Details of Certain Condensed Consolidated Balance Sheet Accounts	3 Months Ended
	Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Details of Certain Condensed Consolidated Balance Sheet Accounts	Note 8. Details of Certain Condensed Consolidated Balance Sheet Accounts Accounts receivable and contract assets, net (in thousands): March 31, December 31, 2024 2023 Accounts receivable $ 25,961 $ 24,574 Contract assets 9,366 6,225 Allowance for credit losses ( 126 ) ( 99 ) $ 35,201 $ 30,700 Prepaid expenses and other current assets (in thousands): March 31, December 31, 2024 2023 Deferred commissions $ 1,385 $ 1,295 Prepaid software and licenses 946 1,147 Short-term deposits 467 406 Prepaid insurance 399 806 Other 310 248 $ 3,507 $ 3,902 Other assets (long-term) (in thousands): March 31, December 31, 2024 2023 Deferred commissions $ 3,275 $ 3,205 Escrow claim (Note 4 - Acquisitions) 581 581 Other 169 123 $ 4,025 $ 3,909 Accrued expenses and other current liabilities (in thousands): March 31, December 31, 2024 2023 Personnel-related accruals $ 4,818 $ 6,500 Operating lease liabilities 981 964 Professional fees 371 407 Sales/use tax payable 125 100 State income tax payable 201 128 Other 605 422 $ 7,101 $ 8,521 Other liabilities (long-term) (in thousands): March 31, December 31, 2024 2023 Operating lease liabilities $ 1,279 $ 1,542 Contingent consideration liability 554 554 $ 1,833 $ 2,096

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Note 9. Related Party Transactions During the three months ended March 31, 2024, the Company recognized approximat ely $ 33 in revenues from SoundThinking Labs projects with charitable organizations that have received donations from one of the Company’s former directors and from one of the Company’s significant stockholders. There were no related party transactions in the three months ended March 31, 2023.

Net Income (Loss) per Share

Net Income (Loss) per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Net Income (Loss) per Share	Note 10. Net Income (Loss) per Share The computation of basic net income (loss) per share is based on the weighted-average number of shares of common stock outstanding during each period. The computation of diluted net income (loss) per share is based on the weighted-average number of shares outstanding during the period plus, when their effect is dilutive, incremental shares consisting of shares subject to stock options, restricted stock units, employee stock purchase plan purchase rights and warrants. The following table summarizes the computation of basic and diluted net income (loss) per share (in thousands, except share and per share data): Three Months Ended March 31, 2024 2023 Numerator: Net loss $ ( 2,909 ) $ ( 1,790 ) Denominator: Weighted-average shares outstanding, basic and diluted 12,770,988 12,252,517 Net loss per share, basic and diluted $ ( 0.23 ) $ ( 0.15 ) Th e following potentially dilutive shares outstanding at the end of the periods presented were excluded in the calculation of diluted net loss per share as the effect would have been anti-dilutive: March 31, 2024 2023 Options to purchase common stock 1,819,731 1,461,481 Unvested restricted stock units 1,085,127 337,259 Total 2,904,858 1,798,740

Equity Incentive Plans

Equity Incentive Plans	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans	Note 11. Equity Incentive Plans Stock options A summary of option activities under the 2005 Stock Plan, as amended in January 2010 and November 2012 (the "2005 Plan") and 2017 Equity Incentive Plan (the “2017 Plan") during the three months ended March 31, 2024 is as follows: Number Weighted Weighted Aggregate Intrinsic Value Exercised (in thousands) Outstanding at December 31, 2023 1,789,431 $ 26.83 Granted 51,667 $ 17.74 $ 10.81 Exercised — $ — $ — Canceled ( 21,367 ) $ 25.86 Outstanding at March 31, 2024 1,819,731 $ 26.59 Under an “evergreen” provision, the number of shares of common stock reserved for issuance under the 2017 Plan will automatically increase on January 1 of each year, beginning on January 1, 2018 and ending on and including January 1, 2027 , by 5 % of the total number of shares of the Company's common stock outstanding on December 31 of the preceding calendar year or a lesser number of shares determined by the Board. In accordance with the evergreen provision, the number of shares of common stock reserved for issuance under the 2017 Plan was increased on January 1, 2024 by 638,072 shares, which was equal to 5 % of the total number of shares of common stock outstanding on December 31, 2023. Restricted stock units A summary of restricted stock unit ("RSU") activities under the 2017 Plan during the three months ended March 31, 2024 is as follows: Number Weighted Aggregate Fair Value of RSUs Vested (in thousands) Unvested RSUs at December 31, 2023 298,361 $ 27.58 Granted 817,408 $ 17.74 Vested ( 30,642 ) $ 29.08 $ 4,897 Forfeited — $ — Unvested RSUs at March 31, 2024 1,085,127 $ 20.18 Performance-based restricted stock units: During the three months ended March 31, 2024, the Company granted to members of the Company's management team RSU awards with performance-based vesting conditions (“PSUs”) , totaling 544,228 shares at a grant date fair value of $ 17.74 per share, the closing stock price on the grant date. These PSUs vest in one installment on the certification date, which shall occur as soon as administratively practicable following the end of 2026, based on the satisfaction of certain Company performance criteria in 2026, as determined by the Compensation and Human Capital Committee of the Board of Directors of the Company. Compensation expense related to the PSUs is estimated each period based on the fair value of the target stock unit at the grant date and the most probable level of achievement of the performance conditions. Compensation expense related to these awards was approximately $ 0.1 million for the three months ended March 31, 2024. 2017 Employee Stock Purchase Plan There were no shares of common stock issued under the 2017 Employee Stock Purchase Plan ("2017 ESPP") during the three months ended March 31, 2024. The 2017 ESPP contains an “evergreen” provision that provides for an automatic annual share increase on January 1 of each year, in an amount equal to the lesser of (1) 2 % of the total number of shares of common stock outstanding on December 31st of the preceding calendar year, (2) 150,000 shares or (3) such number of shares as determined by the Board. In accordance with the evergreen provision, the number of shares of common stock reserved for issuance under the 2017 ESPP was increased on January 1, 2024 by 150,000 shares. The number of shares available for grant under the 2017 ESPP was 778,343 as of March 31, 2024. Total stock-based compensation expense associated with the 2005 Plan, 2017 Plan and 2017 ESPP is recorded in the condensed consolidated statements of operations and was allocated as follows (in thousands): Three Months Ended March 31, 2024 2023 Cost of revenues $ 440 $ 474 Sales and marketing 601 439 Research and development 302 295 General and administrative 1,584 1,012 Total $ 2,927 $ 2,220

Financing Arrangements

Financing Arrangements	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Financing Arrangements	Note 12. Financing Arrangements On September 27, 2018 , the Company entered into a Credit Agreement with Umpqua Bank (the “Umpqua Credit Agreement”), which allowed the Company to borrow up to $ 10.0 million under a revolving loan facility (the “Revolving Facility”). On November 23, 2022, the Company entered into a Fifth Amendment to the Umpqua Credit Agreement (the “Amendment”), which amended the terms of the Umpqua Credit Agreement to, among other things, (1) extend the maturity date from November 27, 2022 to October 15, 2024 , (2) increase the revolving credit commitment from $ 20.0 million to $ 25.0 million, (3) increase the letter of credit sub-facility from $ 6.0 million to $ 7.5 million, (4) remove the minimum profitability covenants and (5) replace the LIBOR index rate with a Term Secured Overnight Financing Rate index rate. On February 7, 2024, the Company entered into a Sixth Amendment to extend the expiration date to October 15, 2025. Any amounts outstanding under the letter of credit sub-facility reduce the amount available for the Company to borrow under the Revolving Facility. The available loan facility as of March 31, 2024 and December 31, 2023 was approximately $ 18.0 million, for both periods. As of March 31, 2024 and December 31, 2023, there was $ 7.0 million outstanding on the Company's line of credit, which the Company borrowed in August 2023 to partially fund the acquisition of SafePointe. The interest expense recorded for the three months ended March 31, 2024 was $ 0.1 million, based on a weighted-average interest rate of 7.33 %.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 13. Commitments and Contingencies Contingencies On August 28, 2018, Silvon S. Simmons (the “Plaintiff”) amended a complaint against the City of Rochester, New York and various city employees, filed in the United States District Court, Western District of New York, to add the Company and employees as a defendant. The amended complaint alleges conspiracy to violate the Plaintiff’s civil rights, denial of the right to a fair trial, and malicious prosecution. The Plaintiff claims that the Company colluded with the City of Rochester to fabricate and create gunshot alert evidence to secure Plaintiff’s conviction. On the basis of the allegations, the Plaintiff has petitioned for compensatory and punitive damages and other costs and expenses, including attorney’s fees. The Company believes that the Plaintiff’s claims are without merit and has disputed them vigorously. Following a motion for summary judgment by the Company on September 13, 2023, the court removed the Company as a defendant from the litigation. The Plaintiff then lost its case against the City of Rochester, New York at trial and may appeal. The Company may become subject to legal proceedings, as well as demands and claims that arise in the normal course of business. Such claims, even if not meritorious, could result in the expenditure of significant financial and management resources. The Company makes a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed and adjusted to include the impacts of negotiations, estimated settlements, legal rulings, advice of legal counsel, and other information and events pertaining to a particular matter. An unfavorable outcome on any litigation matters could require payment of substantial damages, or, in connection with any intellectual property infringement claims, could require the Company to pay ongoing royalty payments or could prevent the Company from selling certain of its products. As a result, a settlement of, or an unfavorable outcome on, any of the matters referenced above or other litigation matters could have a material adverse effect on the Company’s business, operating results, financial condition and cash flows.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements include the results of the Company and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated upon consolidation. The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the consolidated financial statements filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (“Annual Report”) filed with the SEC on April 1, 2024. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss, stockholders’ equity and cash flows for the interim periods, but are not necessarily indicative of the results of operations or cash flows to be anticipated for the full year 2024 or any future period. The Company has evaluated subsequent events occurring after the date of the condensed consolidated financial statements for events requiring recording or disclosure in the condensed consolidated financial statements.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its significant estimates, including the valuation of accounts receivable, the lives and realization of tangible and intangible assets, contingent consideration liabilities, stock-based compensation expense, customer life, accounting for revenue recognition, contingent liabilities related to legal matters, and income taxes including deferred taxes and any related valuation allowance. In particular, the Company's contingent consideration liabilities are subject to significant estimates surrounding forecasts of certain revenues and other factors. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could be material to the Company’s financial position and results of operations. The Company records net deferred tax assets to the extent the Company believes these assets will more likely than not be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. In the event the Company determines that it would be able to realize its deferred assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.
Concentrations of Risk	Concentrations of Risk Credit Risk – Financial instruments that potentially subject the Company to concentration of credit risk consisted primarily of cash and cash equivalents and accounts receivable from trade customers. The Company maintains its deposits of cash and cash equivalents at three domestic and four international financial institutions. The Company is exposed to credit risk in the event of default by a financial institution to the extent that cash and cash equivalents are in excess of the amount insured by the Federal Deposit Insurance Corporation ("FDIC") and other local country government agencies. The Company generally places its cash and cash equivalents with high-credit quality financial institutions. To date, the Company has not experienced any losses on its cash and cash equivalents. As of March 31, 2024, the Company had approximately $ 7.6 million, $ 0.3 million and $ 27,000 , deposited with the Company's three domestic financial institutions, for which only $ 250,000 per bank is insured under FDIC limits. Concentration of Accounts Receivable and Contract Assets – At March 31, 2024 , two customers accounted for 25 % and 21 % of the Company’s total accounts receivable and contract assets, net. At December 31, 2023, two customers accounted for 24 % and 10 %, respectively, of the Company’s total accounts receivable and contract assets, net. Concentration of Revenues – For the three months ended March 31, 2024 , two customers accounted for 26 % and 10 % of the Company’s total revenues. For the three months ended March 31, 2023, two customers accounted for 27 % and 10 % of the Company’s total revenues. Concentration of Suppliers – The Company relies on a limited number of suppliers and contract manufacturers. In particular, a single supplier is currently the sole manufacturer of the Company’s proprietary sensors.
Recent Accounting Pronouncements Not Yet Effective	Recent Accounting Pronouncements Not Yet Effective Improvements to Income Tax Disclosures In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 enhances the transparency of income tax disclosures, primarily by requiring public business entities to disclose on an annual basis, specific categories in the rate reconciliation tabular presentation, as well as by providing additional information for reconciling items that meet a quantitative threshold. The ASU also requires disaggregated disclosures of federal, state and foreign income taxes paid. The new guidance is effective for fiscal years beginning after December 15, 2024. The Company does not expect implementation of the new guidance to have a material impact on its condensed consolidated financial statements. Improvements to Reportable Segment Disclosures In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which enhances prior reportable segment disclosure requirements in part by requiring entities to disclose significant expenses related to their reportable segments. The guidance also requires disclosure of the Chief Operating Decision Maker's (“CODM”) position for each segment and detail of how the CODM uses financial reporting to assess their segment’s performance. The new guidance is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, on a retrospective basis, with early adoption permitted. The Company does not expect implementation of the new guidance to have a material impact on its consolidated financial statements.

Revenue Related Disclosures (Ta

Revenue Related Disclosures (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Changes in Deferred Revenue	The changes in deferred revenue were as follows (in thousands): March 31, 2024 2023 Beginning balance $ 42,077 $ 43,721 New billings 33,242 14,149 Revenue recognized during the year from beginning balance ( 14,347 ) ( 14,987 ) Revenue recognized during the year from new billings ( 10,220 ) ( 5,429 ) Foreign currency impact — 5 Ending balance $ 50,752 $ 37,459
Schedule of Remaining Performance Obligations for Contractually Committed Revenues	The following table presents remaining performance obligations for contractually committed revenues as of March 31, 2024 (in thousands): Remainder of 2024 $ 59,125 2025 33,158 2026 16,135 Thereafter 5,340 Total $ 113,758

Acquisitions (Tables)

Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2024
SafePointe, LLC
Business Acquisition [Line Items]
Summary of Assignment of Fair Value to Identified Assets and Liabilities	The following table summarizes the assignment of fair value to the identified assets and liabilities recorded as of the acquisition date (in thousands): Cash and cash equivalents $ 394 Accounts receivable and contract assets 370 Property and equipment, net 717 Customer relationships 2,500 Software technology 9,200 Tradename 1,100 Goodwill 11,242 Other assets 101 Accrued expenses and other current liabilities ( 52 ) Deferred revenue ( 581 ) Net assets acquired 24,991 Escrow claim 581 Total estimated consideration $ 25,572

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Summary of Changes in Fair Value of Contingent Consideration Liabilities	The changes in the fair value of contingent consideration liabilities for the three months ended March 31, 2024 and 2023 are as follows (in thousands): Three Months Ended March 31, 2024 2023 Beginning balance $ 554 $ 4,747 Payment of contingent consideration liability — ( 1,500 ) Change in fair value of contingent consideration — ( 6 ) Ending balance $ 554 $ 3,241

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Goodwill	The change in goodwill is as follows (in thousands): March 31, December 31, 2024 2023 Beginning balance $ 34,213 $ 22,971 Acquisition of SafePointe (Note 4 - Acquisitions) — 11,242 Ending balance $ 34,213 $ 34,213

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets Net	Intangible assets consist of the following (in thousands): March 31, 2024 Weighted Average Amortization Period (in years) Gross Accumulated Amortization Net Customer relationships 14 $ 25,470 $ ( 4,927 ) $ 20,543 Acquired software technology 9 16,340 ( 2,627 ) 13,713 Patents and intellectual property 4 1,988 ( 1,273 ) 715 Tradename 6 2,100 ( 1,076 ) 1,024 Total intangible assets, net $ 45,898 $ ( 9,903 ) $ 35,995 December 31, 2023 Weighted Average Amortization Period (in years) Gross Accumulated Amortization Net Customer relationships 14 $ 25,470 $ ( 4,467 ) $ 21,003 Acquired software technology 9 16,340 ( 2,199 ) 14,141 Patents 4 1,966 ( 1,227 ) 739 Tradename 6 2,100 ( 1,045 ) 1,055 Total intangible assets, net $ 45,876 $ ( 8,938 ) $ 36,938
Schedule of Future Intangible Asset Amortization	The following table presents future intangible asset amortization as of March 31, 2024 (in thousands): Remainder of 2024 $ 2,857 2025 3,818 2026 3,801 2027 3,801 2028 3,736 Thereafter 17,982 Total $ 35,995

Details of Certain Condensed _2

Details of Certain Condensed Consolidated Balance Sheet Accounts (Tables)	3 Months Ended
	Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Schedule of Accounts Receivable and Contract Assets, Net	Accounts receivable and contract assets, net (in thousands): March 31, December 31, 2024 2023 Accounts receivable $ 25,961 $ 24,574 Contract assets 9,366 6,225 Allowance for credit losses ( 126 ) ( 99 ) $ 35,201 $ 30,700
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets (in thousands): March 31, December 31, 2024 2023 Deferred commissions $ 1,385 $ 1,295 Prepaid software and licenses 946 1,147 Short-term deposits 467 406 Prepaid insurance 399 806 Other 310 248 $ 3,507 $ 3,902
Schedule of Other Long-term Assets	Other assets (long-term) (in thousands): March 31, December 31, 2024 2023 Deferred commissions $ 3,275 $ 3,205 Escrow claim (Note 4 - Acquisitions) 581 581 Other 169 123 $ 4,025 $ 3,909
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities (in thousands): March 31, December 31, 2024 2023 Personnel-related accruals $ 4,818 $ 6,500 Operating lease liabilities 981 964 Professional fees 371 407 Sales/use tax payable 125 100 State income tax payable 201 128 Other 605 422 $ 7,101 $ 8,521
Schedule of Other Long-term Liabilities	Other liabilities (long-term) (in thousands): March 31, December 31, 2024 2023 Operating lease liabilities $ 1,279 $ 1,542 Contingent consideration liability 554 554 $ 1,833 $ 2,096

Net Income (Loss) per Share (Ta

Net Income (Loss) per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Summary of Computation of Basic and Diluted Net Income (Loss) per Share	The following table summarizes the computation of basic and diluted net income (loss) per share (in thousands, except share and per share data): Three Months Ended March 31, 2024 2023 Numerator: Net loss $ ( 2,909 ) $ ( 1,790 ) Denominator: Weighted-average shares outstanding, basic and diluted 12,770,988 12,252,517 Net loss per share, basic and diluted $ ( 0.23 ) $ ( 0.15 )
Schedule of Anti-dilutive Shares Outstanding Excluded in Calculation of Diluted Net Loss per Share	Th e following potentially dilutive shares outstanding at the end of the periods presented were excluded in the calculation of diluted net loss per share as the effect would have been anti-dilutive: March 31, 2024 2023 Options to purchase common stock 1,819,731 1,461,481 Unvested restricted stock units 1,085,127 337,259 Total 2,904,858 1,798,740

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	A summary of option activities under the 2005 Stock Plan, as amended in January 2010 and November 2012 (the "2005 Plan") and 2017 Equity Incentive Plan (the “2017 Plan") during the three months ended March 31, 2024 is as follows: Number Weighted Weighted Aggregate Intrinsic Value Exercised (in thousands) Outstanding at December 31, 2023 1,789,431 $ 26.83 Granted 51,667 $ 17.74 $ 10.81 Exercised — $ — $ — Canceled ( 21,367 ) $ 25.86 Outstanding at March 31, 2024 1,819,731 $ 26.59
Schedule of Unvested Restricted Stock Units Awards Activity	A summary of restricted stock unit ("RSU") activities under the 2017 Plan during the three months ended March 31, 2024 is as follows: Number Weighted Aggregate Fair Value of RSUs Vested (in thousands) Unvested RSUs at December 31, 2023 298,361 $ 27.58 Granted 817,408 $ 17.74 Vested ( 30,642 ) $ 29.08 $ 4,897 Forfeited — $ — Unvested RSUs at March 31, 2024 1,085,127 $ 20.18
Schedule of Stock-Based Compensation Expense for All Award Types Recorded in Consolidated Statements of Operations	Total stock-based compensation expense associated with the 2005 Plan, 2017 Plan and 2017 ESPP is recorded in the condensed consolidated statements of operations and was allocated as follows (in thousands): Three Months Ended March 31, 2024 2023 Cost of revenues $ 440 $ 474 Sales and marketing 601 439 Research and development 302 295 General and administrative 1,584 1,012 Total $ 2,927 $ 2,220

Organization and Description _2

Organization and Description of Business - Additional Information (Details)	3 Months Ended
	Mar. 31, 2024 City Universities Agencies Customers Subsidiary
Business And Nature Of Operations [Line Items]
Number of customers	250
Number of agencies | Agencies	2,100
Number of universities and corporations in which entity operates | Universities	18
Number of subsidiary | Subsidiary	6
Maintenance and Support Services and Professional Software Development Services
Business And Nature Of Operations [Line Items]
Number of customers	2
Minimum
Business And Nature Of Operations [Line Items]
Number of cities in which entity operates | City	171

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2024 USD ($) Customer Customers Financialinstitution	Mar. 31, 2023 Customer	Dec. 31, 2023 USD ($) Customer
Accounting Policies [Line Items]
Number of customers | Customers	250
Cash and cash equivalents	$ 8,524,000		$ 5,703,000
Customer Concentration Risk | Accounts Receivable and Contract Assets
Accounting Policies [Line Items]
Number of customers | Customer	2		2
Customer Concentration Risk | Revenues
Accounting Policies [Line Items]
Number of customers | Customer	2	2
Customer Concentration Risk | Customer One | Accounts Receivable and Contract Assets
Accounting Policies [Line Items]
Concentration risk percentage		25%	24%
Customer Concentration Risk | Customer One | Revenues
Accounting Policies [Line Items]
Concentration risk percentage	26%	27%
Customer Concentration Risk | Customer Two | Accounts Receivable and Contract Assets
Accounting Policies [Line Items]
Concentration risk percentage		21%	10%
Customer Concentration Risk | Customer Two | Revenues
Accounting Policies [Line Items]
Concentration risk percentage	10%	10%
Credit Concentration Risk
Accounting Policies [Line Items]
Cash deposits insured	$ 250,000
Credit Concentration Risk | United States
Accounting Policies [Line Items]
Number of financial institutions at which cash deposits are maintained | Financialinstitution	3
Credit Concentration Risk | International
Accounting Policies [Line Items]
Number of financial institutions at which cash deposits are maintained | Financialinstitution	4
Credit Concentration Risk | Domestic Financial Institution One
Accounting Policies [Line Items]
Cash and cash equivalents	$ 7,600,000
Credit Concentration Risk | Domestic Financial Institution Two
Accounting Policies [Line Items]
Cash and cash equivalents	300,000
Credit Concentration Risk | Domestic Financial Institution Three
Accounting Policies [Line Items]
Cash and cash equivalents	$ 27,000,000

Revenue Related Disclosures - S

Revenue Related Disclosures - Schedule of Changes in Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation Of Revenue [Line Items]
Beginning balance	$ 42,077	$ 43,721
New billings	33,242	14,149
Foreign currency impact		5
Ending balance	50,752	37,459
Recognition From Balance at the Beginning of the Year
Disaggregation Of Revenue [Line Items]
Revenue recognized during the year	(14,347)	(14,987)
Revenue Recognized During the Year from New Billings
Disaggregation Of Revenue [Line Items]
Revenue recognized during the year	$ (10,220)	$ (5,429)

Revenue Related Disclosures -_2

Revenue Related Disclosures - Schedule of Remaining Performance Obligations for Contractually Committed Revenues (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Estimated remaining performance obligations for contractually committed revenues	$ 113,758
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Estimated remaining performance obligations for contractually committed revenues	$ 59,125
Estimated remaining performance obligations for contractually committed revenues recognition period	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Estimated remaining performance obligations for contractually committed revenues	$ 33,158
Estimated remaining performance obligations for contractually committed revenues recognition period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Estimated remaining performance obligations for contractually committed revenues	$ 16,135
Estimated remaining performance obligations for contractually committed revenues recognition period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Estimated remaining performance obligations for contractually committed revenues	$ 5,340
Estimated remaining performance obligations for contractually committed revenues recognition period

Revenue Related Disclosures -_3

Revenue Related Disclosures - Schedule of Remaining Performance Obligations for Contractually Committed Revenues 1 (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Estimated remaining performance obligations for contractually committed revenues	$ 113,758

Revenue Related Disclosures - A

Revenue Related Disclosures - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Subscription, maintenance and support services Member
Disaggregation Of Revenue [Line Items]
Revenues	$ 25.3	$ 19.5
Professional software development services member
Disaggregation Of Revenue [Line Items]
Revenues	0.1	1.1
United States
Disaggregation Of Revenue [Line Items]
Revenues	24.8	20.2
South Africa
Disaggregation Of Revenue [Line Items]
Revenues	0.6	0.4
Bahamas
Disaggregation Of Revenue [Line Items]
Revenues	0.6	$ 0.4
Uruguay
Disaggregation Of Revenue [Line Items]
Revenues	$ 0.6

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2023
Umpqua Credit Agreement
Business Acquisition [Line Items]
Credit facility outstanding	$ 7,000,000	$ 7,000,000		$ 7,000,000
SafePointe, LLC
Business Acquisition [Line Items]
Membership interests, acquired		100%
Business acquisition purchase consideration in cash		$ 11,400,000
Preliminary fair value of the contingent consideration		3,000,000
Business acquisition estimated purchase consideration/purchase consideration		25,600,000
Percentage of discounted cash flows	20.90%
Acquisition-related expenses	$ 0		$ 0
Proforma revenue			21,000,000
Proforma combined loss			$ 2,400,000
SafePointe, LLC | Customer Relationships
Business Acquisition [Line Items]
Business acquisition, intangible assets		2,500,000
Intangible assets amortization period	12 years
SafePointe, LLC | Software technology
Business Acquisition [Line Items]
Intangible assets amortization period	11 years
SafePointe, LLC | Tradename
Business Acquisition [Line Items]
Business acquisition, intangible assets		1,100,000
Intangible assets amortization period	9 years
SafePointe, LLC | Indemnification Escrow
Business Acquisition [Line Items]
Indemnification escrow cash		1,100,000
Business acquisition purchase consideration, stock issued		1,100,000
SafePointe, LLC | Maximum | Indemnification Escrow
Business Acquisition [Line Items]
Earnout will be payable based on estimated revenues generated		$ 11,500,000
SafePointe, LLC | Common Stock
Business Acquisition [Line Items]
Issuance of common stock for acquisition, Shares		549,579
Fair value of common stock issued as consideration for acquisitions		$ 11,200,000

Acquisitions - Summary of Assig

Acquisitions - Summary of Assignment of Fair Value to Identified Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill	$ 34,213	$ 34,213		$ 22,971
SafePointe, LLC
Business Acquisition [Line Items]
Cash and cash equivalents			$ 394
Accounts receivable and contract assets			370
Property and equipment, net			717
Goodwill			11,242
Other assets			101
Accrued expenses and other current liabilities			(52)
Deferred revenue			(581)
Net assets acquired			24,991
Escrow claim			581
Total estimated consideration			25,572
SafePointe, LLC | Customer Relationships
Business Acquisition [Line Items]
Identifiable technology and intangible assets			2,500
SafePointe, LLC | Software Technology
Business Acquisition [Line Items]
Identifiable technology and intangible assets			9,200
SafePointe, LLC | Tradename
Business Acquisition [Line Items]
Identifiable technology and intangible assets			$ 1,100

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Aug. 31, 2023	Dec. 31, 2022	Jan. 31, 2022
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Payment of contingent consideration liability		$ 1,500,000
Transfers into or out of level 3	$ 0	0
Level 3
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Percentage of assets, fair value adjustment				76.10%		60%
Percentage of revenue volatility				25.80%		28%
Fair Value Measurements Recurring | Level 3
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Change in fair value of contingent consideration		(6,000)
Contingent consideration	554,000	3,241,000	$ 554,000		$ 4,747,000
Fair Value Measurements Recurring | Level 3 | Other Liabilities
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Contingent consideration	$ 600,000
Technologic
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Payment of contingent consideration liability		1,500,000
Forensic Logic | Level 3
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Estimated fair value of contingent consideration						$ 12,400,000
Forensic Logic | Fair Value Measurements Recurring | Level 3
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Change in fair value of contingent consideration		$ 10,000
SafePointe, LLC | Level 3
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Estimated fair value of contingent consideration				$ 3,000,000

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Changes in Fair Value of Contingent Consideration Liabilities (Details) - Fair Value Measurements Recurring - Level 3 $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	$ 4,747
Payment of contingent consideration liability	(1,500)
Change in fair value of contingent consideration	(6)
Ending balance	3,241
Forensic Logic
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Change in fair value of contingent consideration	$ 10

Goodwill - Schedule of Changes

Goodwill - Schedule of Changes in Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Goodwill [Line Items]
Beginning balance	$ 34,213	$ 22,971
Ending balance	34,213	34,213
SafePointe, LLC
Goodwill [Line Items]
Acquisition (Note 4 - Acquisitions)	$ 0	$ 11,242

Intangible Assets, Net - Schedu

Intangible Assets, Net - Schedule of Intangible Assets Net (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross	$ 45,898	$ 45,876
Accumulated Amortization	(9,903)	(8,938)
Net	$ 35,995	$ 36,938
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	14 years	14 years
Gross	$ 25,470	$ 25,470
Accumulated Amortization	(4,927)	(4,467)
Net	$ 20,543	$ 21,003
Acquired Software Technology
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	9 years	9 years
Gross	$ 16,340	$ 16,340
Accumulated Amortization	(2,627)	(2,199)
Net	$ 13,713	$ 14,141
Patents
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)		4 years
Gross		$ 1,966
Accumulated Amortization		(1,227)
Net		$ 739
Patents and Intellectual Property
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	4 years
Gross	$ 1,988
Accumulated Amortization	(1,273)
Net	$ 715
Tradename
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	6 years	6 years
Gross	$ 2,100	$ 2,100
Accumulated Amortization	(1,076)	(1,045)
Net	$ 1,024	$ 1,055

Intangible Assets, Net - Additi

Intangible Assets, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangible amortization expense	$ 965	$ 661

Intangible Assets, Net - Sche_2

Intangible Assets, Net - Schedule of Future Intangible Asset Amortization (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Remainder of 2024	$ 2,857
2025	3,818
2026	3,801
2027	3,801
2028	3,736
Thereafter	17,982
Net	$ 35,995	$ 36,938

Details of Certain Condensed _3

Details of Certain Condensed Consolidated Balance Sheet Accounts - Schedule of Accounts Receivable and Contract Assets, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Accounts receivable	$ 25,961	$ 24,574
Contract assets	9,366	6,225
Allowance for credit losses	(126)	(99)
Accounts receivable and contract assets	$ 35,201	$ 30,700

Details of Certain Condensed _4

Details of Certain Condensed Consolidated Balance Sheet Accounts - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Prepaid Expense and Other Assets, Current [Abstract]
Deferred commissions	$ 1,385	$ 1,295
Prepaid software and licenses	946	1,147
Short-term deposits	467	406
Prepaid insurance	399	806
Other	310	248
Total	$ 3,507	$ 3,902

Details of Certain Condensed _5

Details of Certain Condensed Consolidated Balance Sheet Accounts - Schedule of Other Long-term Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Other Assets Noncurrent Disclosure [Abstract]
Deferred commissions	$ 3,275	$ 3,205
Escrow claim (Note 4 - Acquisitions)	581	581
Other	169	123
Total other assets	$ 4,025	$ 3,909

Details of Certain Condensed _6

Details of Certain Condensed Consolidated Balance Sheet Accounts - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accrued Expenses And Other Current Liabilities [Abstract]
Personnel-related accruals	$ 4,818	$ 6,500
Operating lease liabilities	981	964
Professional fees	371	407
Sales/ use tax payable	125	100
State income tax payable	201	128
Other	605	422
Accrued expenses and other current liabilities	$ 7,101	$ 8,521

Details of Certain Condensed _7

Details of Certain Condensed Consolidated Balance Sheet Accounts - Schedule of Other Long-term Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accrued Expenses And Other Current Liabilities [Abstract]
Operating lease liabilities	$ 1,279	$ 1,542
Contingent consideration liability	554	554
Other liabilities, noncurrent	$ 1,833	$ 2,096

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - SoundThinking - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Related Party Transaction [Line Items]
Revenue from related parties	$ 33,000
Related party transactions		$ 0

Net Income (Loss) per Share - S

Net Income (Loss) per Share - Summary of Computation of Basic and Diluted Net Income (Loss) per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Numerator:
Net loss	$ (2,909)	$ (1,790)
Denominator:
Weighted-average shares outstanding, basic	12,770,988	12,252,517
Weighted-average shares outstanding, diluted	12,770,988	12,252,517
Net loss per share, basic	$ (0.23)	$ (0.15)
Net loss per share, diluted	$ (0.23)	$ (0.15)

Net Income (Loss) per Share -_2

Net Income (Loss) per Share - Schedule of Anti-dilutive Shares Outstanding Excluded in Calculation of Diluted Net Income (Loss) per Share (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	2,904,858	1,798,740
Options to Purchase Common Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	1,819,731	1,461,481
Unvested Restricted Stock Units
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	1,085,127	337,259

Equity Incentive Plans - Schedu

Equity Incentive Plans - Schedule of Stock Option Activity (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options Outstanding, Beginning Balance | shares	1,789,431
Number of Options Outstanding, Granted | shares	51,667
Number of Options Outstanding, Canceled | shares	(21,367)
Number of Options Outstanding, Ending Balance | shares	1,819,731
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted Average Exercise Price, Beginning Balance	$ 26.83
Weighted Average Exercise Price, Granted	17.74
Weighted Average Exercise Price, Canceled	25.86
Weighted Average Exercise Price, Ending Balance	26.59
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Grant Date Fair Value per Option, Granted	$ 10.81

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended		12 Months Ended
	Jan. 01, 2024	May 31, 2017	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2017
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Compensation expense			$ 2,927	$ 2,220
Restricted Stock Unit
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of RSUs, Granted			817,408
Grant Date Fair Value, Granted			$ 17.74
Performance-based RSU
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of RSUs, Granted			544,228
Grant Date Fair Value, Granted			$ 17.74
Compensation expense			$ 100
2017 Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares issued under ESPP			0
Number of shares available for future grant			778,343
Shares of common stock reserved for issuance, automatic annual increase initiation period		--01-01
Percentage of number of shares of common stock outstanding					2%
Increase in common stock reserved for issuance	150,000
Periodic increment of common stock reserved for future issuance					150,000
2017 Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares of common stock reserved for issuance, automatic annual increase initiation period		--01-01
Percentage of number of shares of common stock outstanding					5%	5%
Shares of common stock reserved for issuance, automatic annual increase start date		Jan. 01, 2018
Shares of common stock reserved for issuance, automatic annual increase end date		Jan. 01, 2027
Increase in common stock reserved for issuance	638,072

Equity Incentive Plans - Sche_2

Equity Incentive Plans - Schedule of Unvested Restricted Stock Units Awards Activity - (Details) - Restricted Stock Unit $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of RSUs, Beginning Balance | shares	298,361
Number of RSUs, Granted | shares	817,408
Number of RSUs, Vested | shares	(30,642)
Number of RSUs, Ending Balance | shares	1,085,127
Weighted Average Grant Date Fair Value per RSU, Beginning Balance | $ / shares	$ 27.58
Weighted Average Grant Date Fair Value per RSU, Granted | $ / shares	17.74
Weighted Average Grant Date Fair Value per RSU, Vested | $ / shares	29.08
Weighted Average Grant Date Fair Value per RSU, Ending Balance | $ / shares	$ 20.18
Aggregate Fair Value of RSUs' Vested | $	$ 4,897

Equity Incentive Plans - Sche_3

Equity Incentive Plans - Schedule of Stock-Based Compensation Expense Recorded in Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 2,927	$ 2,220
Cost of Revenues
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	440	474
Sales and Marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	601	439
Research and Development
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	302	295
General and Administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 1,584	$ 1,012

Financing Arrangements - Additi

Financing Arrangements - Additional Information (Details) - Umpqua Credit Agreement - USD ($) $ in Millions		3 Months Ended
	Nov. 23, 2022	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Aug. 31, 2020	Sep. 27, 2018
Debt Instrument [Line Items]
Credit facility outstanding		$ 7	$ 7	$ 7
Interest expense		$ 0.1
Weighted-average interest rate		7.33%
Revolving Facility
Debt Instrument [Line Items]
Credit agreement date		Sep. 27, 2018
Credit facility maximum borrowing capacity under loan	$ 25				$ 20	$ 10
Credit facility maturity date	Nov. 27, 2022
Credit facility extended maturity date	Oct. 15, 2024
Credit facility current borrowing capacity under loan		$ 18	$ 18
Letter of Credit Subfacility
Debt Instrument [Line Items]
Credit facility maximum borrowing capacity under loan	$ 7.5					$ 6